ER 50891 (quarterhydrate)

Product Overview

• Article Name: ER 50891 (quarterhydrate)
• Biozol Catalog Number: MCE-HY-108531A
• Supplier Catalog Number: HY-108531A
• Alternative Catalog Number: MCE-HY-108531A-10MG,MCE-HY-108531A-5MG,MCE-HY-108531A-1MG,MCE-HY-108531A-50MG,MCE-HY-108531A-100MG,MCE-HY-108531A-25MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien

Product Description

ER 50891 quarterhydrate is a RARalpha antagonist. ER 50891 can significantly antagonize the inhibitory effect of all-trans retinoic acid (ATRA) on the total cell metabolic activity and proliferation of MC3T3-E1 preosteoblasts. ER 50891 rescues ATRA-inhibited osteocalcin (OCN) expression and extracellular matrix mineralization, and suppresses alkaline phosphatase (ALP) activity synergistically. ER 50891 can be used for the study of osteoporosis related to ATRA-induced inhibition of osteoblastogenesis[1].

Product Properties

• Molecular Weight: 437.02
• Purity: 99.86
• Formula: C29H24N2O2.1/4H20
• Target: RAR/RXR

Application Notes

• Application Notes: MCE Product type: Reference compound